Bionanoplus logo

Bionanoplus

Innovative solutions in nanoencapsulation

Nanotechnology | Drug Delivery | Technological Innovation | Biotech

Description

Bionanoplus is drug delivery biotechnological company founded in 2010 specialized in providing polymeric nanoencapsulation solutions.
 
Bionanoplus has solved the scalability problem of traditional nanoparticle manufacturing methods avoiding the use of volatile organic solvents, thus ensuring an easy and cheap production at any scale that can be performed using standard equipment and techniques.
 
Bionanoplus has developed several proprietary technology platforms to obtain nanoparticle-based systems without using volatile organic solvents. The main advantages are:
 
  • Our systems maintain the polymeric nanoparticles potential: increased bioavailability, controlled release, and enhanced solubility and stability.
  • No volatile organic solvents means no special equipment or techniques to eliminate the common industrial scale-up issues decisive in many project failures which, together with a low cost of goods, ensures a cost-effectiveness production.
  • All raw materials comply with the regulatory requirements and are commercially available.

Featured projects

  • Funding: The company has raised more than €3.5 million in funding to date and is backed by Start Up Capital Navarra and Inveready, investors specialized in the biotechnology and life sciences sectors.
 
  • Licensing agreements: Bionanoplus has signed two licensing agreements with pharmaceutical companies for the commercialization of an innovative Minoxidil-based product in both national and international markets.

 

  • Patented technologies: The Company has a hybrid and adapted business model and owns 3 robust Patented Technologies: NANOGES, SANP, and MUCOLAST.

 

  • H2020 Projects: Bionanoplus has secured funding for the development of various H2020 projects.

 

SKHINCAPS: SKin Healthcare by Innovative NanoCAPsuleS.

Research project aiming to develop customised and safe nanocapsules to deliver novel products for skin healthcare applications, with increased efficiency and cost benefits, leading to ground-breaking innovations on the actual products.

https://skhincaps.eu/

 
ASINA: Anticipating Safety Issues at the Design Stage of NAno Product Development.
ASINA has the ambition to promote consistent, applicable and scientifically sound Safe-by-Design nano-practices, considering all the of nano-enabled products design dimensions: functionality, production technologies, safety, environmental sustainability, cost effectiveness and regulatory requirements, in line with research responsible innovation policy. 
https://www.asina-project.eu/
Abanza